Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: FDA Consumer Health Information Last Updated: Nov 29, 2012 - 7:11:02 AM


FDA Expands Caution About SimplyThick

By FDA Consumer Health Information
Sep 18, 2012 - 11:31:31 AM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
(HealthNewsDigest.com) - FDA wants parents, caregivers and health care professionals to be aware that infants of any age may face an increased risk of developing a life-threatening condition if fed a thickening product called SimplyThick.

The agency has identified 22 infants who developed necrotizing enterocolitis (NEC), a condition in which tissue in the intestines becomes inflamed and dies, after being fed SimplyThick. Seven of those infants have died. FDA had issued an advisory in May 2011 that warned of the risk to infants born prematurely. Now, FDA is extending that advice to include infants on any age.

SimplyThick is a brand of thickening agent—available to consumers and medical centers—to help manage swallowing difficulties.

###

For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: tvmike13@HealthNewsDigest.com or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, to thousands of journalists in all media, and health-related websites. www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines
+ FDA Approves New Drug for Advanced Prostate Cancer
+ U.S. Marshals Seize Food at New York-based Kosher Food Facility
+ Stimulant DMAA May Endanger Your Health, FDA Warns
+ FDA Issues Proposal to Improve the Quality of Automated Eternal Defibrillators
+ FDA Approves New Treatment for Late-stage Breast Cancer
+ FDA Approves Pomalyst for Advanced Multiple Myeloma
+ FDA Approval of Generic Version of Cancer Drug Doxil is Expected to Help Resolve Shortage
+ Beware of Fraudulent Flu Products
+ FDA Approves Three New Drug Treatments for Type 2 Diabetes
+ FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions